Gamma-hydroxybutyrate increases brain resting-state functional connectivity of the salience network and dorsal nexus in humans

Autor: Oliver G. Bosch, Dario Dornbierer, Robin von Rotz, Michael Kometer, Boris B. Quednow, Michael M. Havranek, Fabrizio Esposito, Philipp Staempfli, Erich Seifritz
Přispěvatelé: Bosch, O. G., Esposito, F., Dornbierer, D., Havranek, M. M., von Rotz, R., Kometer, M., Staempfli, P., Quednow, B. B., Seifritz, E., University of Zurich, Bosch, Oliver G
Jazyk: angličtina
Rok vydání: 2018
Předmět:
2805 Cognitive Neuroscience
Adult
Male
medicine.drug_class
Cognitive Neuroscience
Sedation
Stimulation
610 Medicine & health
050105 experimental psychology
03 medical and health sciences
Young Adult
0302 clinical medicine
Double-Blind Method
Attention network
medicine
Humans
Fronto-parietal network
0501 psychology and cognitive sciences
10064 Neuroscience Center Zurich
Intrinsic connectivity
Default mode network
Brain Mapping
Resting state fMRI
business.industry
Sodium oxybate
05 social sciences
Brain
Gamma hydroxybutyrate
GABA-B Receptor Agonist
Magnetic Resonance Imaging
Pharmaco-fMRI
Dorsomedial prefrontal cortex
Neurology
Sedative
10054 Clinic for Psychiatry
Psychotherapy
and Psychosomatics

2808 Neurology
GABA-B Receptor Agonists
medicine.symptom
Nerve Net
business
Neurocognitive
Insula
Neuroscience
030217 neurology & neurosurgery
Human
Popis: According to the triple network hypothesis the brain is equipped with three core neurocognitive networks: the default mode (DMN), the salience (SN), and the central executive (CEN) network. Moreover, the so called dorsal nexus, has met growing interest as it is a hub region connecting these three networks. Assessment of resting-state functional connectivity (rsFC) of these networks enables the elucidation of drug-induced brain alterations. Gamma-hydroxybutyrate (GHB) is a GHB/GABA-B receptor agonist that induces a paradoxical state of mixed stimulation and sedation at moderate doses, which makes it a valuable tool to investigate neural signatures of subjective drug effects. Employing a placebo-controlled, double-blind, randomized, cross-over design, we assessed the effects of GHB (35 mg/kg p. o.) in 19 healthy male subjects on DMN-, SN-, CEN-, and dorsal nexus-rsFC measured by functional magnet resonance imaging and applying independent component as well as seed-based analyses, while subjective drug effects were investigated using visual analog scales (VAS). Subjectively, GHB increased VAS ratings of a general drug effect, stimulation, and sedation. Intrinsic DMN-, and CEN-rsFC remained largely unchanged under GHB, but the drug increased SN-DMN-rsFC and SN-dorsal nexus-rsFC, while dorsal nexus-rsFC was reciprocally increased to both the SN (right anterior insula) and to the CEN (right middle frontal gyrus). Increased sedation significantly predicted the observed SN-dorsal nexus-rsFC. In conclusion, GHB generates a unique stimulant/sedative subjective state that is paralleled by a complex pattern of increased functional connectivity encompassing all three core neurocognitive networks of the brain, while increased SN-dorsal nexus-rsFC was demonstrated to be a potential signature of the sedative component of the drug effect.
Databáze: OpenAIRE